Anguita, E;
Gupta, R;
Olariu, V;
Valk, PJ;
Peterson, C;
Delwel, R;
Enver, T;
(2016)
A somatic mutation of GFI1B identified in leukemia alters cell fate via a SPI1 (PU.1) centered genetic regulatory network.
Developmental Biology
, 411
(2)
pp. 277-286.
10.1016/j.ydbio.2016.02.002.
Preview |
Text
Enver_a somatic mutation of GFI1B_in leukemia_aam.pdf - Accepted Version Download (3MB) | Preview |
Abstract
We identify a mutation (D262N) in the erythroid-affiliated transcriptional repressor GFI1B, in an acute myeloid leukemia (AML) patient with antecedent myelodysplastic syndrome (MDS). The GFI1B-D262N mutant functionally antagonizes the transcriptional activity of wild-type GFI1B. GFI1B-D262N promoted myelomonocytic versus erythroid output from primary human hematopoietic precursors and enhanced cell survival of both normal and MDS derived precursors. Re-analysis of AML transcriptome data identifies a distinct group of patients in whom expression of wild-type GFI1B and SPI1 (PU.1) have an inverse pattern. In delineating this GFI1B-SPI1 relationship we show that (i) SPI1 is a direct target of GFI1B, (ii) expression of GFI1B-D262N produces elevated expression of SPI1, and (iii) SPI1-knockdown restores balanced lineage output from GFI1B-D262N-expressing precursors. These results table the SPI1-GFI1B transcriptional network as an important regulatory axis in AML as well as in the development of erythroid versus myelomonocytic cell fate.
Type: | Article |
---|---|
Title: | A somatic mutation of GFI1B identified in leukemia alters cell fate via a SPI1 (PU.1) centered genetic regulatory network |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1016/j.ydbio.2016.02.002 |
Publisher version: | https://doi.org/10.1016/j.ydbio.2016.02.002 |
Language: | English |
Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
Keywords: | Science & Technology, Life Sciences & Biomedicine, Developmental Biology, GFI1B, SPI1, PU.1, Transcriptional networks, Acute myeloid leukemia, Myelodysplastic syndrome, ACUTE MYELOID-LEUKEMIA, TRANSCRIPTIONAL REPRESSOR GFI1, ZINC-FINGER PROTEIN, HEMATOPOIETIC STEM, PROGENITOR CELLS, FACTOR-BINDING, DIFFERENTIATION, GFI-1B, EXPRESSION, LINEAGES |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Cancer Bio UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Haematology |
URI: | https://discovery-pp.ucl.ac.uk/id/eprint/1537050 |
Archive Staff Only
![]() |
View Item |